Juan Pablo Alderuccio

机构：University of Miami, Sylvester Comprehensive Cancer Center · ORCID：0000-0002-2690-3377

发表论文 183 篇 · 总被引 1938 次 · h-index 23

代表论文

• ABCL-777: Initial Results From LOTIS-7: A Phase 1b Study of Loncastuximab Tesirine Plus Glofitamab in Patients With Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) (2025 · Clinical Lymphoma Myeloma & Leukemia · 被引 9)
• Impact of extranodal involvement at CAR T-cell therapy on outcomes in patients with relapsed or refractory large B-cell lymphoma—Results from a multicenter cohort study (2025 · Blood Cancer Journal · 被引 9)
• The treatment of marginal zone lymphoma (2025 · Blood · 被引 8)
• Treatment-related outcomes and patterns of relapse in secondary CNS involvement by large B-cell lymphoma (2026 · Blood · 被引 6)
• 78 | INITIAL RESULTS FROM LOTIS‐7: A PHASE 1B STUDY OF LONCASTUXIMAB TESIRINE PLUS GLOFITAMAB IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) (2025 · Hematological Oncology · 被引 4)
• Immunodeficiency-associated primary CNS lymphomas: an International Primary CNS Lymphoma Collaborative Group study (2026 · Blood · 被引 3)